M. METİNTAŞ Et Al. , "Effectivity of chemotherapy regimen included carboplatin ifosfamide etoposide with or without adding interferon alpha 2a in treatment of patients with small cell lung carcinoma," 15.ERS YILLIK KONGRESİ , 2005
METİNTAŞ, M. Et Al. 2005. Effectivity of chemotherapy regimen included carboplatin ifosfamide etoposide with or without adding interferon alpha 2a in treatment of patients with small cell lung carcinoma. 15.ERS YILLIK KONGRESİ .
METİNTAŞ, M., AK, G., ERGİNEL, M. S., ALATAŞ, F., KURT, E., UÇGUN, İ., ... YILDIRIM, H.(2005). Effectivity of chemotherapy regimen included carboplatin ifosfamide etoposide with or without adding interferon alpha 2a in treatment of patients with small cell lung carcinoma . 15.ERS YILLIK KONGRESİ
METİNTAŞ, MUZAFFER Et Al. "Effectivity of chemotherapy regimen included carboplatin ifosfamide etoposide with or without adding interferon alpha 2a in treatment of patients with small cell lung carcinoma," 15.ERS YILLIK KONGRESİ, 2005
METİNTAŞ, MUZAFFER Et Al. "Effectivity of chemotherapy regimen included carboplatin ifosfamide etoposide with or without adding interferon alpha 2a in treatment of patients with small cell lung carcinoma." 15.ERS YILLIK KONGRESİ , 2005
METİNTAŞ, M. Et Al. (2005) . "Effectivity of chemotherapy regimen included carboplatin ifosfamide etoposide with or without adding interferon alpha 2a in treatment of patients with small cell lung carcinoma." 15.ERS YILLIK KONGRESİ .
@conferencepaper{conferencepaper, author={MUZAFFER METİNTAŞ Et Al. }, title={Effectivity of chemotherapy regimen included carboplatin ifosfamide etoposide with or without adding interferon alpha 2a in treatment of patients with small cell lung carcinoma}, congress name={15.ERS YILLIK KONGRESİ}, city={}, country={}, year={2005}}